Documented security problems with compounded semaglutide include dosing problems from incorrect compounding or mislabeling, contamination with microbes or other hazardous substances during preparation, presence of impurities or unintended elements, usage of non-pharmaceutical quality active components from unregistered suppliers, and inconsistent p